N/A
N=6,350
Universal HIV Screening and Targeted HCV Screening in Emergency Department
Hepatitis C · Hiv
Bottom Line
View on ClinicalTrials.gov: NCT03595527 ↗Enrolled (actual)
6,350
Serious AEs
0.0%
Results posted
Feb 2023
Primary outcome: Primary: Prevalence — 78; 118; 2; 9 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- HIV and HCV screening (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Primary completion
- Oct 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Prevalence |
78; 118; 2; 9 | — |
| SECONDARY Prevalence Among Baby-boomers |
7 | — |
| SECONDARY Opt-out |
1479; 1487 | — |
| SECONDARY Initial Workup |
2; 3 | — |
| SECONDARY Cascade of Care |
1; 2 | — |
Summary
Cross-sectional study of patients consulting in the emergency room of the Centre hospitalier de l'Université de Montréal (CHUM), to assess the implementation of an "opt-out" screening program for HIV and HCV and prospective follow-up for 3 months of positive cases.
Eligibility Criteria
Inclusion Criteria
- Individuals attending the emergency room of the Centre hospitalier de l'Université de Montréal
Exclusion Criteria
- Individuals unable to opt-out due to their psychological or physical condition
Data sourced from ClinicalTrials.gov (NCT03595527). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.